Skip to Main Content

Paper Details

Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models.
Oncotarget
32
2019
4T1 breast cancer model, Anti-KLRG1, B16F10, B16F10 melanoma, KLRG1, MC38, MC38 colon cancer, T, anti-KLRG1, anti-KLRG1 antibody, anti-PD-1, anti-PD-1 antibody, breast cancer, cancer, colon cancer, cytotoxic T, cytotoxic T and NK cell, human, human blood, human tumor samples, late, late-differentiated effector and effector memory CD8+ T and NK cells, lung metastases, murine, tumor, tumor samples
Author NameAffiliation
Steven M GreenbergBrigham and Women's Hospital and Harvard Medical School
Steven M GreenbergBoston Children's Hospital
Sek Won KongBoston Children's Hospital
Sek Won KongHarvard Medical School
Stefano V Gull??Inc.
  • 1 - 5

Datasets

Release 1.2